MET amplification as a potential therapeutic target against hepatocellular carcinoma

Hepatol Res. 2021 Nov;51(11):1093-1094. doi: 10.1111/hepr.13702.

Author

Yuji Eso¹

Affiliation

¹ Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

PMID: 34724292
DOI: 10.1111/hepr.13702

No abstract available

Keywords: MET amplification; cabozantinib; hepatocellular carcinoma; hepatocyte growth factor; tivantinib.

Publication types

Editorial